Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Virus Hospitalizations”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Not applicableStudy completedNCT01754428
What this trial is testing

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences 2,432
Testing effectiveness (Phase 2)Ended earlyNCT02935673
What this trial is testing

Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Viruses
Janssen Research & Development, LLC 49
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Early research (Phase 1)Study completedNCT02202356
What this trial is testing

ALS-008176 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 183
Not applicableUnknownNCT05562817
What this trial is testing

The Epidemiology , Health and Economic Burden of RSV Amongst Hospitalized Children Under 5 Years of Age in Jordan

Who this might be right for
Respiratory Syncytial Virus Infections
MENA Center for Research & Development and Internship 1,200
Not applicableActive Not RecruitingNCT06647654
What this trial is testing

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Who this might be right for
Respiratory Syncytial VirusRespiratory Tract Diseases
Pfizer 1
Early research (Phase 1)Ended earlyNCT02460016
What this trial is testing

AK0529 in Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 1
Not applicableLooking for participantsNCT07239583
What this trial is testing

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

Who this might be right for
Respiratory Syncytial Virus InfectionRespiratory Syncytial Virus Infections
Tam Anh Research Institute 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03418571
What this trial is testing

Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection

Who this might be right for
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Ablynx, a Sanofi company 15
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Not applicableActive Not RecruitingNCT07122661
What this trial is testing

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Syncytial VirusLower Respiratory Tract Disease+2 more
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT02135614
What this trial is testing

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Gilead Sciences 189
Large-scale testing (Phase 3)Looking for participantsNCT06775405
What this trial is testing

Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Who this might be right for
Respiratory Synctial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 180
Not applicableStudy completedNCT03574532
What this trial is testing

Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

Who this might be right for
Respiratory Tract Infections
Janssen-Cilag International NV 118
Testing effectiveness (Phase 2)Study completedNCT02654171
What this trial is testing

Viral Inhibition in Children for Treatment of RSV

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Shanghai Ark Biopharmaceutical Co., Ltd. 72
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Testing effectiveness (Phase 2)Study completedNCT06942299
What this trial is testing

AK0529 in Adults Patients Hospitalized With RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT06206720
What this trial is testing

Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infection
Vigonvita Life Sciences 60
Not applicableActive Not RecruitingNCT06993753
What this trial is testing

Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Viral (RSV) Infections
Griffith University 4,350
Not applicableStudy completedNCT00421304
What this trial is testing

Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness

Who this might be right for
RSV Illness in ≤12 Months of Participants
MedImmune LLC 118
Load More Results